Revelation Biosciences, Inc. (REVBW) revenue by segment

REVBWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVB

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 6/30

$0.01+0.00 (0.00%)

Close on Oct 30, 2026Market cap $16.05MP/E –Yield –

Revelation Biosciences, Inc. revenue by segment

Revelation Biosciences does not break out revenue by segment, region or product in the tagged data of its filings for this period type.